Recent studies reported that the dysregulation of CREBZF regulated the development of several cancers including melanoma, medulloblastoma, gastric adenocarcinoma, and osteosarcoma, by affecting tumor cell proliferation and apoptosis [18–20]. The gene discussed is CREBZF; the disease is medulloblastoma.